NASDAQ: NEPH - Nephros, Inc.

半年間の収益性: -26.98%
セクタ: Healthcare

プロモーションスケジュール Nephros, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

さらに詳しく
The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

Выручка 0.0103
EBITDA -0.0032
Число акций ао 0.01039 млрд
P/S 6.46
P/BV 8.68
EV/EBITDA -20.58
Цена ао 2.21
ISIN US6406714005
Сайт https://www.nephros.com
Валюта usd
IPO date 2004-09-21
Sector Consumer Discretionary
Industry Household Durables
Валюта отчета usd
1日あたりの価格変動: 0% (1.57)
週ごとの価格変動: -12.29% (1.79)
月ごとの料金変更: -16.93% (1.89)
3ヶ月間の価格変動: -24.52% (2.08)
半年間の価格変動: -26.98% (2.15)
年間の価格変動: +3.97% (1.51)
3年間の価格推移: -82.02% (8.73)
5年間の価格推移: -76.49% (6.6781)
年初からの価格変動: -6.55% (1.68)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 2.25 6
P/BV 3.84 4
P/E 0 0
EV/EBITDA -21.48 0
合計: 3.5

効率

名前 意味 学年
ROA, % -13.28 0
ROE, % -18.84 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -1.33 10
合計: 9.4

成長の衝動

名前 意味 学年
収益性 Revenue, % 38.23 5
収益性 Ebitda, % -56.91 0
収益性 EPS, % -64.02 0
合計: 1
さらに詳しく

機関 音量 共有, %
Wexford Capital LP 3682724 48
Bard Associates Inc. 187318 2.44
Vanguard Group Inc 171310 2.23
Geode Capital Management, LLC 71037 0.93
HighTower Advisors, LLC 56710 0.74
Blair (William) & Company, L.L.C. 36249 0.47
Morgan Stanley 33774 0.44
Elkhorn Partners Limited Partnership 31900 0.42
State Street Corporation 15698 0.2
Mesirow Financial Investment Management, Inc. 15383 0.2

ETF 共有, % 年間の利益率, % 配当金, %
Dimensional U.S. Core Equity 2 ETF 0 30.755198832543 1.47098



スーパーバイザー 役職 支払い 生年
Mr. Robert Banks President, CEO & Director 474.04k 1975 (49 年)
Ms. Judy F. Krandel C.F.A. Chief Financial Officer 147.01k 1965 (59 年)
Brianne McGuire Director of Brand, Marketing & Business Development N/A
Vashone R. Thomas Vice President of Quality, Regulatory, & Human Resources N/A
Mr. Greg Lucas President of Aether Water Systems N/A
Ms. Judy Mazzini Controller N/A
Mr. Alfred Vargas Director of Operations N/A
Mr. Daron G. Evans M.B.A., M.S. Chief Executive Officer of Specialty Renal Products, Inc 300.18k 1974 (50 年)

住所: United States, South Orange. NJ, 380 Lackawanna Place - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.nephros.com